ABX-100031

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameABX-100031
Drug Alias Nameanti-IL-1beta mAbs (Abgenix)anti-IL-1beta mAbs (Amgen)ABX-100032ABX-100031
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbgenix Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncAbgenix Incorporated
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A